2025 annual financial data
AnaptysBio 2025 Operating margin
Direct answer
Operating margin was 20.42%.
Operating income was 47,896,000 USD and net income was -13,232,000 USD.
Operating cash flow was 19,697,000 USD.
Get free AnaptysBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 234,603,000 USD
- Operating income
- 47,896,000 USD
- Net income
- -13,232,000 USD
- Operating cash flow
- 19,697,000 USD